Translating the untranslated region

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 2963-2971

  Schwerk, Johannes ^a   Savan, Ram ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA; RNA BINDING PROTEIN; TRANS ACTING FACTOR; 3' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; ADAPTIVE IMMUNITY; CELL STRESS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOGENETICS; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFECTION; INNATE IMMUNITY; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REVIEW; RNA TRANSLATION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; GENETICS; REGULATORY SEQUENCE; RNA PROCESSING;

3' UNTRANSLATED REGIONS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; POLYADENYLATION; REGULATORY SEQUENCES, NUCLEIC ACID; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, LONG NONCODING; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84942436934     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500756     Document Type: Review

References (147)

1. The ENCODE Project Consortium. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74.
2. The ENCODE Project Consortium. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
3. Carpenter, S., E. P. Ricci, B. C. Mercier, M. J. Moore, and K. A. Fitzgerald. 2014. Post-transcriptional regulation of gene expression in innate immunity. Nat. Rev. Immunol. 14: 361-376.
4. Kafasla, P., A. Skliris, and D. L. Kontoyiannis. 2014. Post-transcriptional coordination of immunological responses by RNA-binding proteins. Nat. Immunol. 15: 492-502.
5. Savan, R. 2014. Post-transcriptional regulation of interferons and their signaling pathways. J. Interferon Cytokine Res. 34: 318-329.
6. Ivanov, P., and P. Anderson. 2013. Post-transcriptional regulatory networks in immunity. Immunol. Rev. 253: 253-272.
7. Lodish, H. F., B. Zhou, G. Liu, and C. Z. Chen. 2008. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 8: 120-130.
8. Jia, J., P. Yao, A. Arif, and P. L. Fox. 2013. Regulation and dysregulation of 39UTR-mediated translational control. Curr. Opin. Genet. Dev. 23: 29-34.
9. Khabar, K. S. 2005. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J. Interferon Cytokine Res. 25: 1-10.
10. Lee, R. C., R. L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
11. Lau, N. C., L. P. Lim, E. G. Weinstein, and D. P. Bartel. 2001. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862.
12. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
13. Chi, S. W., G. J. Hannon, and R. B. Darnell. 2012. An alternative mode of microRNA target recognition. Nat. Struct. Mol. Biol. 19: 321-327.
14. Bagga, S., J. Bracht, S. Hunter, K. Massirer, J. Holtz, R. Eachus, and A. E. Pasquinelli. 2005. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122: 553-563.
15. Giraldez, A. J., Y. Mishima, J. Rihel, R. J. Grocock, S. Van Dongen, K. Inoue, A. J. Enright, and A. F. Schier. 2006. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312: 75-79.
16. Chen, C. Z., L. Li, H. F. Lodish, and D. P. Bartel. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
17. Cobb, B. S., T. B. Nesterova, E. Thompson, A. Hertweck, E. O'Connor, J. Godwin, C. B. Wilson, N. Brockdorff, A. G. Fisher, S. T. Smale, and M. Merkenschlager. 2005. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 201: 1367-1373.
18. Muljo, S. A., K. M. Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202: 261-269.
19. Xiao, C., D. P. Calado, G. Galler, T. H. Thai, H. C. Patterson, J. Wang, N. Rajewsky, T. P. Bender, and K. Rajewsky. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
20. Kurowska-Stolarska, M., S. Alivernini, L. E. Ballantine, D. L. Asquith, N. L. Millar, D. S. Gilchrist, J. Reilly, M. Ierna, A. R. Fraser, B. Stolarski, et al. 2011. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. USA 108: 11193-11198.
21. O'Connell, R. M., D. Kahn, W. S. Gibson, J. L. Round, R. L. Scholz, A. A. Chaudhuri, M. E. Kahn, D. S. Rao, and D. Baltimore. 2010. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619.
22. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
23. Thai, T. H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
24. Lu, L. F., T. H. Thai, D. P. Calado, A. Chaudhry, M. Kubo, K. Tanaka, G. B. Loeb, H. Lee, A. Yoshimura, K. Rajewsky, and A. Y. Rudensky. 2009. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91.
25. Gracias, D. T., E. Stelekati, J. L. Hope, A. C. Boesteanu, T. A. Doering, J. Norton, Y. M. Mueller, J. A. Fraietta, E. J. Wherry, M. Turner, et al. 2013. The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling. Nat. Immunol. 14: 593-602.
26. Leng, R. X., H. F. Pan, W. Z. Qin, G. M. Chen, and D. Q. Ye. 2011. Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev. 22: 141-147.
27. Vigorito, E., S. Kohlhaas, D. Lu, and R. Leyland. 2013. miR-155: an ancient regulator of the immune system. Immunol. Rev. 253: 146-157.
28. Baumjohann, D., and K. M. Ansel. 2013. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat. Rev. Immunol. 13: 666-678.
29. Stittrich, A. B., C. Haftmann, E. Sgouroudis, A. A. Kühl, A. N. Hegazy, I. Panse, R. Riedel, M. Flossdorf, J. Dong, F. Fuhrmann, et al. 2010. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat. Immunol. 11: 1057-1062.
30. Li, Q. J., J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
31. Steiner, D. F., M. F. Thomas, J. K. Hu, Z. Yang, J. E. Babiarz, C. D. Allen, M. Matloubian, R. Blelloch, and K. M. Ansel. 2011. MicroRNA-29 regulates T-box transcription factors and interferon-g production in helper T cells. Immunity 35: 169-181.
32. Ma, F., S. Xu, X. Liu, Q. Zhang, X. Xu, M. Liu, M. Hua, N. Li, H. Yao, and X. Cao. 2011. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-g. Nat. Immunol. 12: 861-869.
33. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
34. Zhao, J. L., D. S. Rao, M. P. Boldin, K. D. Taganov, R. M. O'Connell, and D. Baltimore. 2011. NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. USA 108: 9184-9189.
35. Boldin, M. P., K. D. Taganov, D. S. Rao, L. Yang, J. L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, J. Xu, et al. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208: 1189-1201.
36. Nahid, M. A., M. Satoh, and E. K. Chan. 2011. MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8: 388-403.
37. O'Neill, L. A., F. J. Sheedy, and C. E. McCoy. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11: 163-175.
38. Johnnidis, J. B., M. H. Harris, R. T. Wheeler, S. Stehling-Sun, M. H. Lam, O. Kirak, T. R. Brummelkamp, M. D. Fleming, and F. D. Camargo. 2008. Regulation of progenitor cell proliferation and granulocyte function by micro-RNA-223. Nature 451: 1125-1129.
39. Fukao, T., Y. Fukuda, K. Kiga, J. Sharif, K. Hino, Y. Enomoto, A. Kawamura, K. Nakamura, T. Takeuchi, and M. Tanabe. 2007. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129: 617-631.
40. McFarland, A. P., S. M. Horner, A. Jarret, R. C. Joslyn, E. Bindewald, B. A. Shapiro, D. A. Delker, C. H. Hagedorn, M. Carrington,M. Gale, Jr., and R. Savan. 2014. The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs. Nat. Immunol. 15: 72-79.
41. Cullen, B. R. 2006. Viruses and microRNAs. Nat. Genet. 38(Suppl): S25-S30.
42. David, M. 2010. Interferons and microRNAs. J. Interferon Cytokine Res. 30: 825-828.
43. Tang, Y., X. Luo, H. Cui, X. Ni, M. Yuan, Y. Guo, X. Huang, H. Zhou, N. de Vries, P. P. Tak, et al. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60: 1065-1075.
44. Ceribelli, A., M. Satoh, and E. K. Chan. 2012. MicroRNAs and autoimmunity. Curr. Opin. Immunol. 24: 686-691.
45. Pauley, K. M., M. Satoh, A. L. Chan, M. R. Bubb, W. H. Reeves, and E. K. Chan. 2008. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 10: R101.
46. Xiao, C., L. Srinivasan, D. P. Calado, H. C. Patterson, B. Zhang, J. Wang, J. M. Henderson, J. L. Kutok, and K. Rajewsky. 2008. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9: 405-414.
47. Chen, C. Z., S. Schaffert, R. Fragoso, and C. Loh. 2013. Regulation of immune responses and tolerance: the microRNA perspective. Immunol. Rev. 253: 112-128.
48. O'Connell, R. M., D. S. Rao, and D. Baltimore. 2012. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30: 295-312.
49. Schwerk, J., A. P. Jarret, R. C. Joslyn, and R. Savan. 2015. Landscape of posttranscriptional gene regulation during hepatitis C virus infection. Curr. Opin. Virol. 12: 75-84.
50. Asson-Batres, M. A., S. L. Spurgeon, J. Diaz, T. G. DeLoughery, and G. C. Bagby, Jr. 1994. Evolutionary conservation of the AU-rich 39 untranslated region of messenger RNA. Proc. Natl. Acad. Sci. USA 91: 1318-1322.
51. Bakheet, T., B. R. Williams, and K. S. Khabar. 2006. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res. 34: D111-D114.
52. Gillis, P., and J. S. Malter. 1991. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs. J. Biol. Chem. 266: 3172-3177.
53. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 39-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83: 1670-1674.
54. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 39 untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667.
55. Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20: 465-470.
56. Taylor, G. A., W. S. Lai, R. J. Oakey, M. F. Seldin, T. B. Shows, R. L. Eddy, Jr., and P. J. Blackshear. 1991. The human TTP protein: sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res. 19: 3454.
57. Chen, C. Y., R. Gherzi, S. E. Ong, E. L. Chan, R. Raijmakers, G. J. Pruijn, G. Stoecklin, C. Moroni, M. Mann, and M. Karin. 2001. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107: 451-464.
58. Lykke-Andersen, J., and E. Wagner. 2005. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 19: 351-361.
59. Sandler, H., J. Kreth, H. T. Timmers, and G. Stoecklin. 2011. Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res. 39: 4373-4386.
60. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445-454.
61. Carballo, E., W. S. Lai, and P. J. Blackshear. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005.
62. Carballo, E., W. S. Lai, and P. J. Blackshear. 2000. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95: 1891-1899.
63. Datta, S., R. Biswas, M. Novotny, P. G. Pavicic, Jr., T. Herjan, P. Mandal, and T. A. Hamilton. 2008. Tristetraprolin regulates CXCL1 (KC) mRNA stability. J. Immunol. 180: 2545-2552.
64. Gu, L., H.Ning, X. Qian, Q.Huang, R. Hou, R. Almourani, M. Fu, P. J. Blackshear, and J. Liu. 2013. Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation. J. Immunol. 191: 3922-3930.
65. Kang, J. G., M. J. Amar, A. T. Remaley, J. Kwon, P. J. Blackshear, P. Y. Wang, and P. M. Hwang. 2011. Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation. J. Immunol. 187: 2696-2701.
66. Lee, H. H., N. A. Yoon, M. T. Vo, C. W. Kim, J. M. Woo, H. J. Cha, Y. W. Cho, B. J. Lee, W. J. Cho, and J. W. Park. 2012. Tristetraprolin down-regulates IL-17 through mRNA destabilization. FEBS Lett. 586: 41-46.
67. Molle, C., T. Zhang, L. Ysebrant de Lendonck, C. Gueydan, M. Andrianne, F. Sherer, G. Van Simaeys, P. J. Blackshear, O. Leo, and S. Goriely. 2013. Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease. J. Exp. Med. 210: 1675-1684.
68. Ogilvie, R. L., J. R. Sternjohn, B. Rattenbacher, I. A. Vlasova, D. A. Williams, H. H. Hau, P. J. Blackshear, and P. R. Bohjanen. 2009. Tristetraprolin mediates interferon-gamma mRNA decay. J. Biol. Chem. 284: 11216-11223.
69. Qian, X., H. Ning, J. Zhang, D. F. Hoft, D. J. Stumpo, P. J. Blackshear, and J. Liu. 2011. Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin. J. Immunol. 186: 6454-6464.
70. Stoecklin, G., S. A. Tenenbaum, T. Mayo, S. V. Chittur, A. D. George, T. E. Baroni, P. J. Blackshear, and P. Anderson. 2008. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 283: 11689-11699.
71. Carrick, D. M., P. Chulada, R. Donn, M. Fabris, J. McNicholl, W. Whitworth, and P. J. Blackshear. 2006. Genetic variations in ZFP36 and their possible relationship to autoimmune diseases. J. Autoimmun. 26: 182-196.
72. Stoecklin, G., P. Stoeckle, M. Lu, O. Muehlemann, and C. Moroni. 2001. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 7: 1578-1588.
73. Stoecklin, G., M. Colombi, I. Raineri, S. Leuenberger, M. Mallaun, M. Schmidlin, B. Gross, M. Lu, T. Kitamura, and C. Moroni. 2002. Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J. 21: 4709-4718.
74. Winzen, R., B. K. Thakur, O. Dittrich-Breiholz, M. Shah, N. Redich, S. Dhamija, M. Kracht, and H. Holtmann. 2007. Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets. Mol. Cell. Biol. 27: 8388-8400.
75. Gherzi, R., K. Y. Lee, P. Briata, D. Wegmüller, C. Moroni, M. Karin, andC. Y. Chen. 2004. A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol. Cell 14: 571-583.
76. Lin, W. J., X. Zheng, C. C. Lin, J. Tsao, X. Zhu, J. J. Cody, J. M. Coleman, R. Gherzi, M. Luo, T. M. Townes, et al. 2011. Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection. Mol. Cell. Biol. 31: 3196-3207.
77. Trabucchi, M., P. Briata, M. Garcia-Mayoral, A. D. Haase, W. Filipowicz, A. Ramos, R. Gherzi, and M. G. Rosenfeld. 2009. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459: 1010-1014.
78. Glasmacher, E., K. P. Hoefig, K. U. Vogel, N. Rath, L. Du, C. Wolf, E. Kremmer, X. Wang, and V. Heissmeyer. 2010. Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression. Nat. Immunol. 11: 725-733.
79. Yu, D., A. H. Tan, X. Hu, V. Athanasopoulos, N. Simpson, D. G. Silva, A. Hutloff, K. M. Giles, P. J. Leedman, K. P. Lam, et al. 2007. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450: 299-303.
80. Srivastava, M., G. Duan, N. J. Kershaw, V. Athanasopoulos, J. H. Yeo, T. Ose, D. Hu, S. H. Brown, S. Jergic, H. R. Patel, et al. 2015. Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis. Nat. Commun. 6: 6253.
81. Vinuesa, C. G., M. C. Cook, C. Angelucci, V. Athanasopoulos, L. Rui, K. M. Hill, D. Yu, H. Domaschenz, B. Whittle, T. Lambe, et al. 2005. A RINGtype ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435: 452-458.
82. Leppek, K., J. Schott, S. Reitter, F. Poetz, M. C. Hammond, and G. Stoecklin. 2013. Roquin promotes constitutive mRNA decay via a conserved class of stemloop recognition motifs. Cell 153: 869-881.
83. Pratama, A., R. R. Ramiscal, D. G. Silva, S. K. Das, V. Athanasopoulos, J. Fitch, N. K. Botelho, P. P. Chang, X. Hu, J. J. Hogan, et al. 2013. Roquin-2 shares functions with its paralog Roquin-1 in the repression of mRNAs controlling T follicular helper cells and systemic inflammation. Immunity 38: 669-680.
84. Vogel, K. U., S. L. Edelmann, K. M. Jeltsch, A. Bertossi, K. Heger, G. A. Heinz, J. Zöller, S. C. Warth, K. P. Hoefig, C. Lohs, et al. 2013. Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity 38: 655-668.
85. Matsushita, K., O. Takeuchi, D. M. Standley, Y. Kumagai, T. Kawagoe, T. Miyake, T. Satoh, H. Kato, T. Tsujimura, H. Nakamura, and S. Akira. 2009. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458: 1185-1190.
86. Uehata, T., H. Iwasaki, A. Vandenbon, K. Matsushita, E. Hernandez-Cuellar, K. Kuniyoshi, T. Satoh, T. Mino, Y. Suzuki, D. M. Standley, et al. 2013. Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation. Cell 153: 1036-1049.
87. Jeltsch, K. M., D. Hu, S. Brenner, J. Zöller, G. A. Heinz, D. Nagel, K. U. Vogel, N. Rehage, S. C. Warth, S. L. Edelmann, et al. 2014. Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation. Nat. Immunol. 15: 1079-1089.
88. Mino, T., Y. Murakawa, A. Fukao, A. Vandenbon, H. H. Wessels, D. Ori, T. Uehata, S. Tartey, S. Akira, Y. Suzuki, et al. 2015. Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms. Cell 161: 1058-1073.
89. Ma, W. J., S. Cheng, C. Campbell, A. Wright, and H. Furneaux. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271: 8144-8151.
90. Brennan, C. M., and J. A. Steitz. 2001. HuR and mRNA stability. Cell. Mol. Life Sci. 58: 266-277.
91. Peng, S. S., C. Y. Chen, N. Xu, and A. B. Shyu. 1998. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17: 3461-3470.
92. Di Marco, S., Z. Hel, C. Lachance, H. Furneaux, and D. Radzioch. 2001. Polymorphism in the 39-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. Nucleic Acids Res. 29: 863-871.
93. Dean, J. L., R. Wait, K. R. Mahtani, G. Sully, A. R. Clark, and J. Saklatvala. 2001. The 39 untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell. Biol. 21: 721-730.
94. Ogilvie, R. L., M. Abelson, H. H. Hau, I. Vlasova, P. J. Blackshear, and P. R. Bohjanen. 2005. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 174: 953-961.
95. Young, L. E., S. Sanduja, K. Bemis-Standoli, E. A. Pena, R. L. Price, and D. A. Dixon. 2009. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 136: 1669-1679.
96. Srikantan, S., K. Tominaga, and M. Gorospe. 2012. Functional interplay between RNA-binding protein HuR and microRNAs. Curr. Protein Pept. Sci. 13: 372-379.
97. Brewer, G., S. Saccani, S. Sarkar, A. Lewis, and S. Pestka. 2003. Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A + U-rich element binding factor AUF1. J. Interferon Cytokine Res. 23: 553-564.
98. Raineri, I., D. Wegmueller, B. Gross, U. Certa, and C. Moroni. 2004. Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res. 32: 1279-1288.
99. Loflin, P., C. Y. Chen, and A. B. Shyu. 1999. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 13: 1884-1897.
100. Sarkar, B., Q. Xi, C. He, and R. J. Schneider. 2003. Selective degradation of AUrich mRNAs promoted by the p37 AUF1 protein isoform. Mol. Cell. Biol. 23: 6685-6693.
101. Xu, N., C. Y. Chen, and A. B. Shyu. 2001. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol. Cell. Biol. 21: 6960-6971.
102. Abdelmohsen, K., K. Tominaga-Yamanaka, S. Srikantan, J. H. Yoon, M. J. Kang, and M. Gorospe. 2012. RNA-binding protein AUF1 represses Dicer expression. Nucleic Acids Res. 40: 11531-11544.
103. Wu, X., S. Chesoni, G. Rondeau, C. Tempesta, R. Patel, S. Charles, N. Daginawala, B. E. Zucconi, A. Kishor, G. Xu, et al. 2013. Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected target mRNAs. Nucleic Acids Res. 41: 2644-2658.
104. Carballo, E., H. Cao, W. S. Lai, E. A. Kennington, D. Campbell, and P. J. Blackshear. 2001. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J. Biol. Chem. 276: 42580-42587.
105. Mahtani, K. R., M. Brook, J. L. Dean, G. Sully, J. Saklatvala, and A. R. Clark. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21: 6461-6469.
106. Stoecklin, G., T. Stubbs, N. Kedersha, S. Wax, W. F. Rigby, T. K. Blackwell, and P. Anderson. 2004. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23: 1313-1324.
107. Chrestensen, C. A., M. J. Schroeder, J. Shabanowitz, D. F. Hunt, J. W. Pelo, M. T. Worthington, and T. W. Sturgill. 2004. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J. Biol. Chem. 279: 10176-10184.
108. Tiedje, C., N. Ronkina, M. Tehrani, S. Dhamija, K. Laass, H. Holtmann, A. Kotlyarov, and M. Gaestel. 2012. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet. 8: e1002977.
109. Beaudoin, M., P. Goyette, G. Boucher, K. S. Lo, M. A. Rivas, C. Stevens, A. Alikashani, M. Ladouceur, D. Ellinghaus, L. Törkvist, et al. 2013. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet. 9: e1003723.
110. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
111. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
112. Graham, R. R., S. V. Kozyrev, E. C. Baechler, M. V. P.L. Reddy, R. M. Plenge, J. W. Bauer, W. A. Ortmann, T. Koeuth, M. F. G. Escribano, B. Pons-Estel, et al. 2006. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38: 550-555.
113. Rivas, M. A., M. Beaudoin, A. Gardet, C. Stevens, Y. Sharma, C. K. Zhang, G. Boucher, S. Ripke, D. Ellinghaus, N. Burtt, et al. 2011. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 43: 1066-1073.
114. Sethupathy, P., and F. S. Collins. 2008. MicroRNA target site polymorphisms and human disease. Trends Genet. 24: 489-497.
115. Tanaka, Y., N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, N. Sakamoto, M. Nakagawa, M. Korenaga, K. Hino, S. Hige, et al. 2009. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet. 41: 1105-1109.
116. Fellay, J., K. V. Shianna, D. Ge, S. Colombo, B. Ledergerber, M.Weale, K. Zhang, C. Gumbs, A. Castagna, A. Cossarizza, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
117. Thomas, R., R. Apps, Y. Qi, X. Gao, V. Male, C. O'hUigin, G. O'Connor, D. Ge, J. Fellay, J. N. Martin, et al. 2009. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 41: 1290-1294.
118. Kulkarni, S., R. Savan, Y. Qi, X. Gao, Y. Yuki, S. E. Bass, M. P. Martin, P. Hunt, S. G. Deeks, A. Telenti, et al. 2011. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472: 495-498.
119. Zwiers, A., L. Kraal, T. C. van de Pouw Kraan, T. Wurdinger, G. Bouma, and G. Kraal. 2012. Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production. J. Immunol. 188: 1573-1577.
120. Halvorsen, M., J. S. Martin, S. Broadaway, and A. Laederach. 2010. Diseaseassociated mutations that alter the RNA structural ensemble. PLoS Genet. 6: e1001074.
121. Bevilacqua, A., M. C. Ceriani, S. Capaccioli, and A. Nicolin. 2003. Posttranscriptional regulation of gene expression by degradation of messenger RNAs. J. Cell. Physiol. 195: 356-372.
122. Tian, B., J. Hu, H. Zhang, and C. S. Lutz. 2005. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 33: 201-212.
123. Edwalds-Gilbert, G., K. L. Veraldi, and C. Milcarek. 1997. Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res. 25: 2547-2561.
124. Elkon, R., A. P. Ugalde, and R. Agami. 2013. Alternative cleavage and polyadenylation: extent, regulation and function. Nat. Rev. Genet. 14: 496-506.
125. Sandberg, R., J. R. Neilson, A. Sarma, P. A. Sharp, and C. B. Burge. 2008. Proliferating cells express mRNAs with shortened 39 untranslated regions and fewer microRNA target sites. Science 320: 1643-1647.
126. Takagaki, Y., R. L. Seipelt, M. L. Peterson, and J. L. Manley. 1996. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain premRNA during B cell differentiation. Cell 87: 941-952.
127. Chuvpilo, S., M. Zimmer, A. Kerstan, J. Glöckner, A. Avots, C. Escher, C. Fischer, I. Inashkina, E. Jankevics, F. Berberich-Siebelt, et al. 1999. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10: 261-269.
128. Sigurdsson, S., G. Nordmark, H. H. Göring, K. Lindroos, A. C. Wiman, G. Sturfelt, A. Jönsen, S. Rantapää-Dahlqvist, B. Möller, J. Kere, et al. 2005. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76: 528-537.
129. Graham, R. R., C. Kyogoku, S. Sigurdsson, I. A. Vlasova, L. R. Davies, E. C. Baechler, R. M. Plenge, T. Koeuth, W. A. Ortmann, G. Hom, et al. 2007. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. USA 104: 6758-6763.
130. Shen, N., Q. Fu, Y. Deng, X. Qian, J. Zhao, K. M. Kaufman, Y. L. Wu, C. Y. Yu, Y. Tang, J. Y. Chen, et al. 2010. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 107: 15838-15843.
131. Tsuzaka, K., I. Fukuhara, Y. Setoyama, K. Yoshimoto, K. Suzuki, T. Abe, and T. Takeuchi. 2003. TCR zeta mRNA with an alternatively spliced 39-untranslated region detected in systemic lupus erythematosus patients leads to the downregulation of TCR zeta and TCR/CD3 complex. J. Immunol. 171: 2496-2503.
132. Lee-Kirsch, M. A., M. Gong, D. Chowdhury, L. Senenko, K. Engel, Y. A. Lee, U. de Silva, S. L. Bailey, T. Witte, T. J. Vyse, et al. 2007. Mutations in the gene encoding the 39-59 DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39: 1065-1067.
133. Mayr, C., and D. P. Bartel. 2009. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
134. Guttman, M., I. Amit, M. Garber, C. French, M. F. Lin, D. Feldser, M. Huarte, O. Zuk, B. W. Carey, J. P. Cassady, et al. 2009. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227.
135. Faghihi, M. A., M. Zhang, J. Huang, F. Modarresi, M. P. Van der Brug, M. A. Nalls, M. R. Cookson, G. St-Laurent, III, and C. Wahlestedt. 2010. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol. 11: R56.
136. Salmena, L., L. Poliseno, Y. Tay, L. Kats, and P. P. Pandolfi. 2011. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146: 353-358.
137. Gong, C., and L. E. Maquat. 2011. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 39 UTRs via Alu elements. Nature 470: 284-288.
138. Fitzgerald, K. A., and D. R. Caffrey. 2014. Long noncoding RNAs in innate and adaptive immunity. Curr. Opin. Immunol. 26: 140-146.
139. Tay, Y., J. Rinn, and P. P. Pandolfi. 2014. The multilayered complexity of ceRNA crosstalk and competition. Nature 505: 344-352.
140. Jing, Q., S. Huang, S. Guth, T. Zarubin, A. Motoyama, J. Chen, F. Di Padova, S. C. Lin, H. Gram, and J. Han. 2005. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120: 623-634.
141. El Gazzar, M., and C. E. McCall. 2010. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J. Biol. Chem. 285: 20940-20951.
142. Ma, F., X. Liu, D. Li, P. Wang, N. Li, L. Lu, and X. Cao. 2010. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J. Immunol. 184: 6053-6059.
143. Balkhi, M. Y., O. H. Iwenofu, N. Bakkar, K. J. Ladner, D. S. Chandler, P. J. Houghton, C. A. London, W. Kraybill, D. Perrotti, C. M. Croce, et al. 2013. miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR. Sci. Signal. 6: ra63.
144. Viswanathan, S. R., G. Q. Daley, and R. I. Gregory. 2008. Selective blockade of microRNA processing by Lin28. Science 320: 97-100.
145. Heo, I., C. Joo, Y. K. Kim, M. Ha, M. J. Yoon, J. Cho, K. H. Yeom, J. Han, and V. N. Kim. 2009. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 138: 696-708.
146. Yuan, J., C. K. Nguyen, X. Liu, C. Kanellopoulou, and S. A. Muljo. 2012. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 335: 1195-1200.
147. Zhao, W., J. L. Pollack, D. P. Blagev, N. Zaitlen, M. T. McManus, and D. J. Erle. 2014. Massively parallel functional annotation of 39 untranslated regions. Nat. Biotechnol. 32: 387-391.